Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 6,830,000 | 9,680,000 | 9,461,000 | 8,890,000 | 9,170,000 |
| Cost of Goods | 2,197,000 | 2,998,000 | 2,938,000 | 2,786,000 | 3,041,000 |
| Gross Profit | 4,633,000 | 6,682,000 | 6,523,000 | 6,104,000 | 6,129,000 |
| Operating Expenses | 3,368,000 | 4,550,000 | 4,569,000 | 4,322,000 | 4,340,000 |
| Operating Income | 1,265,000 | 2,132,000 | 1,954,000 | 1,782,000 | 1,789,000 |
| Interest Expense | 165,000 | 127,000 | 134,000 | 133,000 | 159,000 |
| Other Income | -896,000 | -155,000 | 63,000 | -343,000 | -83,000 |
| Pre-tax Income | 204,000 | 1,850,000 | 1,883,000 | 1,306,000 | 1,547,000 |
| Income Tax | -302,000 | 272,000 | 519,000 | 220,000 | 166,000 |
| Net Income Continuous | 477,000 | 1,651,000 | 1,329,000 | 1,055,000 | 1,366,000 |
| Minority Interests | -19,000 | -23,000 | -27,000 | -32,000 | -27,000 |
| Net Income | $334,000 | $1,628,000 | $1,302,000 | $1,023,000 | $1,339,000 |
| EPS Basic Total Ops | 0.26 | 1.25 | 1.00 | 0.78 | 1.02 |
| EPS Basic Continuous Ops | 0.41 | 1.25 | 1.00 | 0.78 | 1.02 |
| EPS Basic Discontinuous Ops | -0.15 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.26 | 1.25 | 0.99 | 0.78 | 1.02 |
| EPS Diluted Continuous Ops | 0.41 | 1.25 | 0.99 | 0.78 | 1.02 |
| EPS Diluted Discontinuous Ops | -0.15 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $679,000 | $2,575,000 | $2,628,000 | $2,057,000 | $2,326,000 |